Actively Recruiting
Pilot Study of Pharmacogenomic Testing to Improve Safety of Antibiotics, Painkillers, and Mental Health Medications in Children Across Canada
Led by University of British Columbia · Updated on 2026-05-01
150
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research focuses on addressing adverse drug reactions in children taking three common types of medications antibiotics, pain relievers, and mental health drugs. The study aims to test a pharmacogenomic panel that helps predict how these medications might affect individual patients. Researchers will also explore how doctors, pharmacists, patients, and families understand and use these test results. The study involves implementing a pilot program for pharmacogenomic testing to improve medication safety and effectiveness. Data collection forms will be created to gather information from prescribing physicians. Pharmacogenomic reports will be developed to share test results with healthcare providers, patients, and their families. The study will assess the perceptions and use of these tests and reports by all involved parties. Participants will be monitored to provide pharmacogenomic recommendations about the risk of gene-related adverse events before or during treatment with analgesics, antibiotics, or mental health medications. A total of 150 participants will be involved. The study will collect information on how the test results influence medication decisions and safety. Participation may last as long as needed to gather this information, with ongoing communication and data collection from healthcare providers and families.
CONDITIONS
Brief Title
Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System
Research Team
B
Bruce Carleton, PharmD.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here